.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
McKinsey
Johnson and Johnson
Fuji
Novartis
Cerilliant
Baxter
Express Scripts
Accenture

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204147

« Back to Dashboard
NDA 204147 describes PROCHLORPERAZINE EDISYLATE, which is a drug marketed by Hospira, West-ward Pharms Int, Teva Parenteral, Watson Labs, Athenex Inc, Emcure Pharms Ltd, Wyeth Ayerst, Smith And Nephew, Alpharma Us Pharms, Marsam Pharms Llc, and Morton Grove, and is included in fifteen NDAs. It is available from four suppliers. Additional details are available on the PROCHLORPERAZINE EDISYLATE profile page.

The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.

Summary for 204147

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 204147

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 204147

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION 204147 ANDA Heritage Pharmaceuticals Inc. 23155-294 23155-294-41 25 VIAL in 1 PACKAGE (23155-294-41) > 2 mL in 1 VIAL (23155-294-31)
PROCHLORPERAZINE EDISYLATE
prochlorperazine edisylate
INJECTABLE;INJECTION 204147 ANDA Heritage Pharmaceuticals Inc. 23155-294 23155-294-42 10 VIAL in 1 PACKAGE (23155-294-42) > 2 mL in 1 VIAL (23155-294-31)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/ML
Approval Date:Oct 15, 2013TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKinsey
Cerilliant
Farmers Insurance
Chinese Patent Office
Harvard Business School
Moodys
Federal Trade Commission
QuintilesIMS
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot